The global market for Leber's Hereditary Optic Neuropathy Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Leber's Hereditary Optic Neuropathy Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Leber's Hereditary Optic Neuropathy Drug.

The Leber's Hereditary Optic Neuropathy Drug market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Leber's Hereditary Optic Neuropathy Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Leber's Hereditary Optic Neuropathy Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Leber's Hereditary Optic Neuropathy Drug Market Report

Report Metric	Details
Report Name	Leber's Hereditary Optic Neuropathy Drug Market
CAGR	5%
Segment by Type	Elamipretide GS-011 IXC-201 KH-176 Others
Segment by Application	Hospital Clinic Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Alkeus Pharmaceuticals, Inc., Biovista Inc., GenSight Biologics S.A., Ixchel Pharma, LLC, Khondrion BV, Spark Therapeutics, Inc., Stealth BioTherapeutics Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Leber's Hereditary Optic Neuropathy Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Leber's Hereditary Optic Neuropathy Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Leber's Hereditary Optic Neuropathy Drug Market report?

Ans: The main players in the Leber's Hereditary Optic Neuropathy Drug Market are Alkeus Pharmaceuticals, Inc., Biovista Inc., GenSight Biologics S.A., Ixchel Pharma, LLC, Khondrion BV, Spark Therapeutics, Inc., Stealth BioTherapeutics Inc.

What are the Application segmentation covered in the Leber's Hereditary Optic Neuropathy Drug Market report?

Ans: The Applications covered in the Leber's Hereditary Optic Neuropathy Drug Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Leber's Hereditary Optic Neuropathy Drug Market report?

Ans: The Types covered in the Leber's Hereditary Optic Neuropathy Drug Market report are Elamipretide, GS-011, IXC-201, KH-176, Others

1 Leber's Hereditary Optic Neuropathy Drug Market Overview

1.1 Product Definition

1.2 Leber's Hereditary Optic Neuropathy Drug by Type

1.2.1 Global Leber's Hereditary Optic Neuropathy Drug Market Value Comparison by Type (2024 VS 2031)

1.2.2 Elamipretide

1.2.3 GS-011

1.2.4 IXC-201

1.2.5 KH-176

1.2.6 Others

1.3 Leber's Hereditary Optic Neuropathy Drug by Application

1.3.1 Global Leber's Hereditary Optic Neuropathy Drug Market Value by Application (2024 VS 2031)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Global Leber's Hereditary Optic Neuropathy Drug Market Size Estimates and Forecasts

1.4.1 Global Leber's Hereditary Optic Neuropathy Drug Revenue 2020-2031

1.4.2 Global Leber's Hereditary Optic Neuropathy Drug Sales 2020-2031

1.4.3 Global Leber's Hereditary Optic Neuropathy Drug Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Leber's Hereditary Optic Neuropathy Drug Market Competition by Manufacturers

2.1 Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Manufacturers (2020-2025)

2.2 Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Leber's Hereditary Optic Neuropathy Drug Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Leber's Hereditary Optic Neuropathy Drug, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Leber's Hereditary Optic Neuropathy Drug, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Leber's Hereditary Optic Neuropathy Drug, Product Type & Application

2.7 Global Key Manufacturers of Leber's Hereditary Optic Neuropathy Drug, Date of Enter into This Industry

2.8 Global Leber's Hereditary Optic Neuropathy Drug Market Competitive Situation and Trends

2.8.1 Global Leber's Hereditary Optic Neuropathy Drug Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Leber's Hereditary Optic Neuropathy Drug Players Market Share by Revenue

2.8.3 Global Leber's Hereditary Optic Neuropathy Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Leber's Hereditary Optic Neuropathy Drug Market Scenario by Region

3.1 Global Leber's Hereditary Optic Neuropathy Drug Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Leber's Hereditary Optic Neuropathy Drug Sales by Region: 2020-2031

3.2.1 Global Leber's Hereditary Optic Neuropathy Drug Sales by Region: 2020-2025

3.2.2 Global Leber's Hereditary Optic Neuropathy Drug Sales by Region: 2026-2031

3.3 Global Leber's Hereditary Optic Neuropathy Drug Revenue by Region: 2020-2031

3.3.1 Global Leber's Hereditary Optic Neuropathy Drug Revenue by Region: 2020-2025

3.3.2 Global Leber's Hereditary Optic Neuropathy Drug Revenue by Region: 2026-2031

3.4 North America Leber's Hereditary Optic Neuropathy Drug Market Facts & Figures by Country

3.4.1 North America Leber's Hereditary Optic Neuropathy Drug Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Leber's Hereditary Optic Neuropathy Drug Sales by Country (2020-2031)

3.4.3 North America Leber's Hereditary Optic Neuropathy Drug Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Leber's Hereditary Optic Neuropathy Drug Market Facts & Figures by Country

3.5.1 Europe Leber's Hereditary Optic Neuropathy Drug Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Leber's Hereditary Optic Neuropathy Drug Sales by Country (2020-2031)

3.5.3 Europe Leber's Hereditary Optic Neuropathy Drug Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Leber's Hereditary Optic Neuropathy Drug Market Facts & Figures by Region

3.6.1 Asia Pacific Leber's Hereditary Optic Neuropathy Drug Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Leber's Hereditary Optic Neuropathy Drug Sales by Region (2020-2031)

3.6.3 Asia Pacific Leber's Hereditary Optic Neuropathy Drug Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Leber's Hereditary Optic Neuropathy Drug Market Facts & Figures by Country

3.7.1 Latin America Leber's Hereditary Optic Neuropathy Drug Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Leber's Hereditary Optic Neuropathy Drug Sales by Country (2020-2031)

3.7.3 Latin America Leber's Hereditary Optic Neuropathy Drug Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Leber's Hereditary Optic Neuropathy Drug Market Facts & Figures by Country

3.8.1 Middle East and Africa Leber's Hereditary Optic Neuropathy Drug Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Leber's Hereditary Optic Neuropathy Drug Sales by Country (2020-2031)

3.8.3 Middle East and Africa Leber's Hereditary Optic Neuropathy Drug Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Leber's Hereditary Optic Neuropathy Drug Sales by Type (2020-2031)

4.1.1 Global Leber's Hereditary Optic Neuropathy Drug Sales by Type (2020-2025)

4.1.2 Global Leber's Hereditary Optic Neuropathy Drug Sales by Type (2026-2031)

4.1.3 Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Type (2020-2031)

4.2 Global Leber's Hereditary Optic Neuropathy Drug Revenue by Type (2020-2031)

4.2.1 Global Leber's Hereditary Optic Neuropathy Drug Revenue by Type (2020-2025)

4.2.2 Global Leber's Hereditary Optic Neuropathy Drug Revenue by Type (2026-2031)

4.2.3 Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Type (2020-2031)

4.3 Global Leber's Hereditary Optic Neuropathy Drug Price by Type (2020-2031)

5 Segment by Application

5.1 Global Leber's Hereditary Optic Neuropathy Drug Sales by Application (2020-2031)

5.1.1 Global Leber's Hereditary Optic Neuropathy Drug Sales by Application (2020-2025)

5.1.2 Global Leber's Hereditary Optic Neuropathy Drug Sales by Application (2026-2031)

5.1.3 Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Application (2020-2031)

5.2 Global Leber's Hereditary Optic Neuropathy Drug Revenue by Application (2020-2031)

5.2.1 Global Leber's Hereditary Optic Neuropathy Drug Revenue by Application (2020-2025)

5.2.2 Global Leber's Hereditary Optic Neuropathy Drug Revenue by Application (2026-2031)

5.2.3 Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Application (2020-2031)

5.3 Global Leber's Hereditary Optic Neuropathy Drug Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Alkeus Pharmaceuticals, Inc.

6.1.1 Alkeus Pharmaceuticals, Inc. Company Information

6.1.2 Alkeus Pharmaceuticals, Inc. Description and Business Overview

6.1.3 Alkeus Pharmaceuticals, Inc. Leber's Hereditary Optic Neuropathy Drug Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Alkeus Pharmaceuticals, Inc. Leber's Hereditary Optic Neuropathy Drug Product Portfolio

6.1.5 Alkeus Pharmaceuticals, Inc. Recent Developments/Updates

6.2 Biovista Inc.

6.2.1 Biovista Inc. Company Information

6.2.2 Biovista Inc. Description and Business Overview

6.2.3 Biovista Inc. Leber's Hereditary Optic Neuropathy Drug Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Biovista Inc. Leber's Hereditary Optic Neuropathy Drug Product Portfolio

6.2.5 Biovista Inc. Recent Developments/Updates

6.3 GenSight Biologics S.A.

6.3.1 GenSight Biologics S.A. Company Information

6.3.2 GenSight Biologics S.A. Description and Business Overview

6.3.3 GenSight Biologics S.A. Leber's Hereditary Optic Neuropathy Drug Sales, Revenue and Gross Margin (2020-2025)

6.3.4 GenSight Biologics S.A. Leber's Hereditary Optic Neuropathy Drug Product Portfolio

6.3.5 GenSight Biologics S.A. Recent Developments/Updates

6.4 Ixchel Pharma, LLC

6.4.1 Ixchel Pharma, LLC Company Information

6.4.2 Ixchel Pharma, LLC Description and Business Overview

6.4.3 Ixchel Pharma, LLC Leber's Hereditary Optic Neuropathy Drug Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Ixchel Pharma, LLC Leber's Hereditary Optic Neuropathy Drug Product Portfolio

6.4.5 Ixchel Pharma, LLC Recent Developments/Updates

6.5 Khondrion BV

6.5.1 Khondrion BV Company Information

6.5.2 Khondrion BV Description and Business Overview

6.5.3 Khondrion BV Leber's Hereditary Optic Neuropathy Drug Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Khondrion BV Leber's Hereditary Optic Neuropathy Drug Product Portfolio

6.5.5 Khondrion BV Recent Developments/Updates

6.6 Spark Therapeutics, Inc.

6.6.1 Spark Therapeutics, Inc. Company Information

6.6.2 Spark Therapeutics, Inc. Description and Business Overview

6.6.3 Spark Therapeutics, Inc. Leber's Hereditary Optic Neuropathy Drug Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Spark Therapeutics, Inc. Leber's Hereditary Optic Neuropathy Drug Product Portfolio

6.6.5 Spark Therapeutics, Inc. Recent Developments/Updates

6.7 Stealth BioTherapeutics Inc.

6.7.1 Stealth BioTherapeutics Inc. Company Information

6.7.2 Stealth BioTherapeutics Inc. Description and Business Overview

6.7.3 Stealth BioTherapeutics Inc. Leber's Hereditary Optic Neuropathy Drug Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Stealth BioTherapeutics Inc. Leber's Hereditary Optic Neuropathy Drug Product Portfolio

6.7.5 Stealth BioTherapeutics Inc. Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Leber's Hereditary Optic Neuropathy Drug Industry Chain Analysis

7.2 Leber's Hereditary Optic Neuropathy Drug Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Leber's Hereditary Optic Neuropathy Drug Production Mode & Process Analysis

7.4 Leber's Hereditary Optic Neuropathy Drug Sales and Marketing

7.4.1 Leber's Hereditary Optic Neuropathy Drug Sales Channels

7.4.2 Leber's Hereditary Optic Neuropathy Drug Distributors

7.5 Leber's Hereditary Optic Neuropathy Drug Customer Analysis

8 Leber's Hereditary Optic Neuropathy Drug Market Dynamics

8.1 Leber's Hereditary Optic Neuropathy Drug Industry Trends

8.2 Leber's Hereditary Optic Neuropathy Drug Market Drivers

8.3 Leber's Hereditary Optic Neuropathy Drug Market Challenges

8.4 Leber's Hereditary Optic Neuropathy Drug Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Alkeus Pharmaceuticals Inc

Biovista Inc

GenSight Biologics S.A.

Ixchel Pharma LLC

Khondrion BV

Spark Therapeutics Inc

Stealth BioTherapeutics Inc.

List of Tables

Table 1. Global Leber's Hereditary Optic Neuropathy Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Leber's Hereditary Optic Neuropathy Drug Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Leber's Hereditary Optic Neuropathy Drug Market Competitive Situation by Manufacturers in 2024

Table 4. Global Leber's Hereditary Optic Neuropathy Drug Sales (K Pcs) of Key Manufacturers (2020-2025)

Table 5. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Leber's Hereditary Optic Neuropathy Drug Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Leber's Hereditary Optic Neuropathy Drug Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Leber's Hereditary Optic Neuropathy Drug Average Price (USD/Pcs) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Leber's Hereditary Optic Neuropathy Drug, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Leber's Hereditary Optic Neuropathy Drug, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Leber's Hereditary Optic Neuropathy Drug, Product Type & Application

Table 12. Global Key Manufacturers of Leber's Hereditary Optic Neuropathy Drug, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Leber's Hereditary Optic Neuropathy Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Leber's Hereditary Optic Neuropathy Drug as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Leber's Hereditary Optic Neuropathy Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Leber's Hereditary Optic Neuropathy Drug Sales by Region (2020-2025) & (K Pcs)

Table 18. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Region (2020-2025)

Table 19. Global Leber's Hereditary Optic Neuropathy Drug Sales by Region (2026-2031) & (K Pcs)

Table 20. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Region (2026-2031)

Table 21. Global Leber's Hereditary Optic Neuropathy Drug Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Region (2020-2025)

Table 23. Global Leber's Hereditary Optic Neuropathy Drug Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Region (2026-2031)

Table 25. North America Leber's Hereditary Optic Neuropathy Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Leber's Hereditary Optic Neuropathy Drug Sales by Country (2020-2025) & (K Pcs)

Table 27. North America Leber's Hereditary Optic Neuropathy Drug Sales by Country (2026-2031) & (K Pcs)

Table 28. North America Leber's Hereditary Optic Neuropathy Drug Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Leber's Hereditary Optic Neuropathy Drug Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Leber's Hereditary Optic Neuropathy Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Leber's Hereditary Optic Neuropathy Drug Sales by Country (2020-2025) & (K Pcs)

Table 32. Europe Leber's Hereditary Optic Neuropathy Drug Sales by Country (2026-2031) & (K Pcs)

Table 33. Europe Leber's Hereditary Optic Neuropathy Drug Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Leber's Hereditary Optic Neuropathy Drug Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Leber's Hereditary Optic Neuropathy Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Leber's Hereditary Optic Neuropathy Drug Sales by Region (2020-2025) & (K Pcs)

Table 37. Asia Pacific Leber's Hereditary Optic Neuropathy Drug Sales by Region (2026-2031) & (K Pcs)

Table 38. Asia Pacific Leber's Hereditary Optic Neuropathy Drug Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Leber's Hereditary Optic Neuropathy Drug Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Leber's Hereditary Optic Neuropathy Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Leber's Hereditary Optic Neuropathy Drug Sales by Country (2020-2025) & (K Pcs)

Table 42. Latin America Leber's Hereditary Optic Neuropathy Drug Sales by Country (2026-2031) & (K Pcs)

Table 43. Latin America Leber's Hereditary Optic Neuropathy Drug Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Leber's Hereditary Optic Neuropathy Drug Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Leber's Hereditary Optic Neuropathy Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Leber's Hereditary Optic Neuropathy Drug Sales by Country (2020-2025) & (K Pcs)

Table 47. Middle East and Africa Leber's Hereditary Optic Neuropathy Drug Sales by Country (2026-2031) & (K Pcs)

Table 48. Middle East and Africa Leber's Hereditary Optic Neuropathy Drug Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Leber's Hereditary Optic Neuropathy Drug Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Leber's Hereditary Optic Neuropathy Drug Sales (K Pcs) by Type (2020-2025)

Table 51. Global Leber's Hereditary Optic Neuropathy Drug Sales (K Pcs) by Type (2026-2031)

Table 52. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Type (2020-2025)

Table 53. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Type (2026-2031)

Table 54. Global Leber's Hereditary Optic Neuropathy Drug Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Leber's Hereditary Optic Neuropathy Drug Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Type (2020-2025)

Table 57. Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Type (2026-2031)

Table 58. Global Leber's Hereditary Optic Neuropathy Drug Price (USD/Pcs) by Type (2020-2025)

Table 59. Global Leber's Hereditary Optic Neuropathy Drug Price (USD/Pcs) by Type (2026-2031)

Table 60. Global Leber's Hereditary Optic Neuropathy Drug Sales (K Pcs) by Application (2020-2025)

Table 61. Global Leber's Hereditary Optic Neuropathy Drug Sales (K Pcs) by Application (2026-2031)

Table 62. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Application (2020-2025)

Table 63. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Application (2026-2031)

Table 64. Global Leber's Hereditary Optic Neuropathy Drug Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Leber's Hereditary Optic Neuropathy Drug Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Application (2020-2025)

Table 67. Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Application (2026-2031)

Table 68. Global Leber's Hereditary Optic Neuropathy Drug Price (USD/Pcs) by Application (2020-2025)

Table 69. Global Leber's Hereditary Optic Neuropathy Drug Price (USD/Pcs) by Application (2026-2031)

Table 70. Alkeus Pharmaceuticals, Inc. Company Information

Table 71. Alkeus Pharmaceuticals, Inc. Description and Business Overview

Table 72. Alkeus Pharmaceuticals, Inc. Leber's Hereditary Optic Neuropathy Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 73. Alkeus Pharmaceuticals, Inc. Leber's Hereditary Optic Neuropathy Drug Product

Table 74. Alkeus Pharmaceuticals, Inc. Recent Developments/Updates

Table 75. Biovista Inc. Company Information

Table 76. Biovista Inc. Description and Business Overview

Table 77. Biovista Inc. Leber's Hereditary Optic Neuropathy Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 78. Biovista Inc. Leber's Hereditary Optic Neuropathy Drug Product

Table 79. Biovista Inc. Recent Developments/Updates

Table 80. GenSight Biologics S.A. Company Information

Table 81. GenSight Biologics S.A. Description and Business Overview

Table 82. GenSight Biologics S.A. Leber's Hereditary Optic Neuropathy Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 83. GenSight Biologics S.A. Leber's Hereditary Optic Neuropathy Drug Product

Table 84. GenSight Biologics S.A. Recent Developments/Updates

Table 85. Ixchel Pharma, LLC Company Information

Table 86. Ixchel Pharma, LLC Description and Business Overview

Table 87. Ixchel Pharma, LLC Leber's Hereditary Optic Neuropathy Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 88. Ixchel Pharma, LLC Leber's Hereditary Optic Neuropathy Drug Product

Table 89. Ixchel Pharma, LLC Recent Developments/Updates

Table 90. Khondrion BV Company Information

Table 91. Khondrion BV Description and Business Overview

Table 92. Khondrion BV Leber's Hereditary Optic Neuropathy Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 93. Khondrion BV Leber's Hereditary Optic Neuropathy Drug Product

Table 94. Khondrion BV Recent Developments/Updates

Table 95. Spark Therapeutics, Inc. Company Information

Table 96. Spark Therapeutics, Inc. Description and Business Overview

Table 97. Spark Therapeutics, Inc. Leber's Hereditary Optic Neuropathy Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 98. Spark Therapeutics, Inc. Leber's Hereditary Optic Neuropathy Drug Product

Table 99. Spark Therapeutics, Inc. Recent Developments/Updates

Table 100. Stealth BioTherapeutics Inc. Company Information

Table 101. Stealth BioTherapeutics Inc. Description and Business Overview

Table 102. Stealth BioTherapeutics Inc. Leber's Hereditary Optic Neuropathy Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 103. Stealth BioTherapeutics Inc. Leber's Hereditary Optic Neuropathy Drug Product

Table 104. Stealth BioTherapeutics Inc. Recent Developments/Updates

Table 105. Key Raw Materials Lists

Table 106. Raw Materials Key Suppliers Lists

Table 107. Leber's Hereditary Optic Neuropathy Drug Distributors List

Table 108. Leber's Hereditary Optic Neuropathy Drug Customers List

Table 109. Leber's Hereditary Optic Neuropathy Drug Market Trends

Table 110. Leber's Hereditary Optic Neuropathy Drug Market Drivers

Table 111. Leber's Hereditary Optic Neuropathy Drug Market Challenges

Table 112. Leber's Hereditary Optic Neuropathy Drug Market Restraints

Table 113. Research Programs/Design for This Report

Table 114. Key Data Information from Secondary Sources

Table 115. Key Data Information from Primary Sources

Table 116. Authors List of This Report

List of Figures

Figure 1. Product Picture of Leber's Hereditary Optic Neuropathy Drug

Figure 2. Global Leber's Hereditary Optic Neuropathy Drug Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Leber's Hereditary Optic Neuropathy Drug Market Share by Type: 2024 & 2031

Figure 4. Elamipretide Product Picture

Figure 5. GS-011 Product Picture

Figure 6. IXC-201 Product Picture

Figure 7. KH-176 Product Picture

Figure 8. Others Product Picture

Figure 9. Global Leber's Hereditary Optic Neuropathy Drug Market Value by Application (2020-2031) & (US$ Million)

Figure 10. Global Leber's Hereditary Optic Neuropathy Drug Market Share by Application: 2024 & 2031

Figure 11. Hospital

Figure 12. Clinic

Figure 13. Others

Figure 14. Global Leber's Hereditary Optic Neuropathy Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Leber's Hereditary Optic Neuropathy Drug Market Size (2020-2031) & (US$ Million)

Figure 16. Global Leber's Hereditary Optic Neuropathy Drug Sales (2020-2031) & (K Pcs)

Figure 17. Global Leber's Hereditary Optic Neuropathy Drug Average Price (USD/Pcs) & (2020-2031)

Figure 18. Leber's Hereditary Optic Neuropathy Drug Report Years Considered

Figure 19. Leber's Hereditary Optic Neuropathy Drug Sales Share by Manufacturers in 2024

Figure 20. Global Leber's Hereditary Optic Neuropathy Drug Revenue Share by Manufacturers in 2024

Figure 21. Global 5 and 10 Largest Leber's Hereditary Optic Neuropathy Drug Players: Market Share by Revenue in Leber's Hereditary Optic Neuropathy Drug in 2024

Figure 22. Leber's Hereditary Optic Neuropathy Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 23. Global Leber's Hereditary Optic Neuropathy Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 24. North America Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Country (2020-2031)

Figure 25. North America Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Country (2020-2031)

Figure 26. U.S. Leber's Hereditary Optic Neuropathy Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. Canada Leber's Hereditary Optic Neuropathy Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. Europe Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Country (2020-2031)

Figure 29. Europe Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Country (2020-2031)

Figure 30. Germany Leber's Hereditary Optic Neuropathy Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. France Leber's Hereditary Optic Neuropathy Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. U.K. Leber's Hereditary Optic Neuropathy Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Italy Leber's Hereditary Optic Neuropathy Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Russia Leber's Hereditary Optic Neuropathy Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Asia Pacific Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Region (2020-2031)

Figure 36. Asia Pacific Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Region (2020-2031)

Figure 37. China Leber's Hereditary Optic Neuropathy Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Japan Leber's Hereditary Optic Neuropathy Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. South Korea Leber's Hereditary Optic Neuropathy Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. India Leber's Hereditary Optic Neuropathy Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Australia Leber's Hereditary Optic Neuropathy Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Taiwan Leber's Hereditary Optic Neuropathy Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Indonesia Leber's Hereditary Optic Neuropathy Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Thailand Leber's Hereditary Optic Neuropathy Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Malaysia Leber's Hereditary Optic Neuropathy Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Philippines Leber's Hereditary Optic Neuropathy Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Latin America Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Country (2020-2031)

Figure 48. Latin America Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Country (2020-2031)

Figure 49. Mexico Leber's Hereditary Optic Neuropathy Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Brazil Leber's Hereditary Optic Neuropathy Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Argentina Leber's Hereditary Optic Neuropathy Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Middle East and Africa Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Country (2020-2031)

Figure 53. Middle East and Africa Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Country (2020-2031)

Figure 54. Turkey Leber's Hereditary Optic Neuropathy Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. Saudi Arabia Leber's Hereditary Optic Neuropathy Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 56. UAE Leber's Hereditary Optic Neuropathy Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 57. Global Sales Market Share of Leber's Hereditary Optic Neuropathy Drug by Type (2020-2031)

Figure 58. Global Revenue Market Share of Leber's Hereditary Optic Neuropathy Drug by Type (2020-2031)

Figure 59. Global Leber's Hereditary Optic Neuropathy Drug Price (USD/Pcs) by Type (2020-2031)

Figure 60. Global Sales Market Share of Leber's Hereditary Optic Neuropathy Drug by Application (2020-2031)

Figure 61. Global Revenue Market Share of Leber's Hereditary Optic Neuropathy Drug by Application (2020-2031)

Figure 62. Global Leber's Hereditary Optic Neuropathy Drug Price (USD/Pcs) by Application (2020-2031)

Figure 63. Leber's Hereditary Optic Neuropathy Drug Value Chain

Figure 64. Channels of Distribution (Direct Vs Distribution)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions